On July 18, 2026, Ni Xialian—the renowned Chinese-born table tennis legend and Olympic veteran—visited the Tai Ai Peptide Group. She was accompanied throughout the visit by Wu Xia, the Group’s Chairperson. The two parties engaged in in-depth discussions regarding sports health and wellness, the philosophy of national fitness, and the innovative development of the “Big Health” industry, exploring new approaches to the integrated development of sports health and biotechnology.
As a renowned “evergreen” figure in the world of table tennis, Ni Xialian has dedicated decades to her professional career while remaining steadfast in her original passion for the sport. With extensive practical experience in sports health—grounded in a deep commitment to scientific training and physical conditioning—she toured the company’s brand exhibition hall. There, she gained detailed insights into Tai Ai Peptide’s core achievements, including its R&D innovations in small-molecule bioactive peptides, technical expertise, and strategic positioning within the broader health and wellness industry. She highly commended the company’s development philosophy, which focuses on advancing public health and prioritizing technology-driven wellness solutions.
During the exchange, Ni Xialian drew upon her personal experience with long-term, high-intensity training and scientifically grounded wellness practices to share key insights on physical recovery and the maintenance of bodily function for those who exercise. She noted that in the era of “fitness for all,” scientific nutritional supplementation and meticulous health maintenance are crucial, and that professional health-tech products provide robust support for both athletic training and daily wellness routines.
Chairwoman Wu Xia outlined the company’s long-standing R&D strengths and product portfolio within the broad health sector, articulating a development philosophy centered on leveraging bioactive peptide technology to empower public health and promote scientifically grounded exercise and wellness. The two parties engaged in in-depth discussions regarding popular areas such as mass fitness, wellness for the middle-aged and elderly, and scientific nutrition, generating fresh ideas for the industry’s healthy development. This visit and exchange established a bridge between sports health and technology-driven wellness, injecting new momentum into Tai Ai Peptide’s continued commitment to the broad health sector and its efforts to empower the public in pursuing scientifically sound exercise.
Tai Ai Peptide Group
Founded in 1997, Tai Ai Peptide Group has dedicated 29 years to scientific research in the field of peptides. Recognized as a high-tech enterprise and a registered manufacturer and exporter with Customs, the Group has evolved into a comprehensive enterprise integrating the R&D, production, sales, and service of peptide products. Leveraging robust domestic and international research capabilities, Tai Ai Peptide Group has mastered three core technologies—whole-substance chain extraction, single-substance isolation, and proprietary enzymatic hydrolysis. The Group holds numerous national invention and utility model patents and has collaborated with major domestic universities on clinical trials, resulting in over a hundred scientific research achievements. Focusing on full-industry-chain services for small-molecule peptides, the Group operates three major production bases in Langfang (Hebei), Dalian (Liaoning), and Heze (Shandong). Its diverse business portfolio spans food ingredients, pharmaceutical raw materials, health supplements, and foods for special medical or dietary purposes. The company provides comprehensive global solutions, including raw peptide powder, ODM, OEM, and brand agency services. Its annual production capacity for raw peptide powder exceeds 5,000 tons, with products exported to more than 40 countries and regions worldwide.
Post time: Jul-23-2026